Posterior atrophy predicts time to dementia in patients with amyloid-positive mild cognitive impairment

BACKGROUND: In patients with amyloid-positive mild cognitive impairment (MCI), neurodegenerative biomarkers such as medial temporal lobe atrophy (MTA) are useful to predict disease progression to dementia. Although posterior atrophy (PA) is a well-known neurodegenerative biomarker of Alzheimer’s dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Pyun, Jung-Min, Park, Young Ho, Kim, Hang-Rai, Suh, Jeewon, Kang, Min Ju, Kim, Beom Joon, Youn, Young Chul, Jang, Jae-Won, Kim, SangYun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732486/
https://www.ncbi.nlm.nih.gov/pubmed/29246250
http://dx.doi.org/10.1186/s13195-017-0326-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732486/
https://www.ncbi.nlm.nih.gov/pubmed/29246250
http://dx.doi.org/10.1186/s13195-017-0326-y

Ejemplares similares